Compare Docusign Inc (DOCU) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs Twist Bioscience Corp — how do they compare? Docusign Inc trades at $58.51 (market cap $11.33B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Docusign Inc is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Docusign Inc nearer its low. Which is the better fit depends on your goals.
| DOCU | TWST | |
|---|---|---|
Market Cap | $11.33B | $7.72B |
Sector | Technology | Health |
52-Week High | $85.01 | $124.88 |
52-Week Low | $41.75 | $24.16 |
Enterprise Value | $10.70B | $7.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
